Dimetapp-C (Brompheniramine Maleate)

Medically reviewed by . Last updated on November 16, 2023

DIMETAPP®-C

Whitehall-Robins

Brompheniramine Maleate – Codeine Phosphate – Phenylephrine HCl – Phenylpropanolamine HCl

Antihistamine – Cough Suppressant – Decongestant

Indications And Clinical Uses: For the symptomatic relief of coughing, nasal congestion, runny nose, sneezing and lacrimation accompanying the common cold and other upper respiratory infections.

Contra-Indications: Hypersensitivity to any of the ingredients, marked hypertension and in patients receiving MAO inhibitors.

Precautions: Administer with caution to patients with cardiac or peripheral vascular disease, glaucoma, hypertension, hyperthyroidism, bladder neck obstruction, diabetes, chronic lung disease, or shortness of breath and in pregnancy or lactation.

Occupational Hazards: Until the drowsiness potential has been determined, the patient should be cautioned against engaging in operations requiring alertness.

Adverse Reactions: Drowsiness, lassitude, nausea, giddiness, dryness of the mouth, mydriasis, increased irritability or excitement may be encountered rarely. Codeine may produce drug dependence and therefore has the potential for being abused.

Dosage And Administration: Administer every 4 hours, not to exceed 6 doses in a 24-hour period.

Adults: 2 teaspoonfuls (10 mL).

Availability And Storage: Each 5 mL of light blue-colored, grape-flavored syrup contains: brompheniramine maleate 2 mg, phenylpropanolamine hydrochloride 5 mg, phenylephrine hydrochloride 5 mg and codeine phosphate 10 mg. Nonmedicinal ingredients: citric acid, flavors, FD&C Blue No. 1, FD&C Red No. 40, propylene glycol, sodium benzoate, sodium saccharin, sorbitol and water. Energy: 0.23 kJ (0.054 kcal/5 mL).

DIMETAPP®-C Whitehall-Robins Brompheniramine Maleate – Codeine Phosphate – Phenylephrine HCl – Phenylpropanolamine HCl Antihistamine – Cough Suppressant – Decongestant


About

Chris Schwerdt, PharmD is a clinical pharmacist with over two decades of experience in long-term care, pharmacy operations, and regulatory consulting. He has led closed-door pharmacy businesses and serves on Pharmacy & Therapeutics committees for both industry and government programs. His work focuses on medication policy development, formulary strategy, and optimizing patient care through drug utilization review. Chris is affiliated with ASCP, ASHP, and the National Association of Boards of Pharmacy.

Connected Diseases :

Common Cold

General Illness Information Medical Term: Upper Respiratory Infection, URI Common name: Common Cold Description: A contagious viral infection of the upper-respiratory passages Causes: Any of at…

Allergic Rhinitis

General Illness Information Common Name: Hay Fever Medical Term: Allergic Rhinitis Description: Allergic response to airborne inhaled allergens affecting the upper respiratory tract (nose, sinuses,…